Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Clinical Neurology and Neurosurgery
|
February 19, 2013
Severe acute motor neuropathy after treatment with triple tyrosine kinase inhibitor BIBF 1120 (Nintedanib)
R Patejdl, S Markmann, R Benecke, et al.
Archives of Gynecology and Obstetrics
|
April 4, 2003
Unilateral ovarian agenesis: report of three cases and review of the literature
I Mylonas, S Hansch, S Markmann, et al.
Oncology
|
November 27, 2001
Effectiveness of Trastuzumab (Herceptin) in a patient with locally recurrent breast cancer after cardiac failure caused by severe cytotoxic pretreatment
B Gerber, A Krause, S Markmann, et al.
Annals of Biomedical Engineering
|
June 2, 2018
Toward a Flexible Variable Stiffness Endoport for Single-Site Partial Nephrectomy
E Amanov, T-D Nguyen, S Markmann, et al.
MMW Fortschritte Der Medizin
|
April 28, 2009
[Chronic rhinosinusitis and aspirin intolerance]
A Leunig, F Braunschweig, M Havel, et al.
Archives of Gynecology and Obstetrics
|
November 30, 2005
WITHDRAWN: The safety of synthetic paclitaxel by intralesional delivery with OncoGeltrade mark into skin breast cancer metastases: method and results of a clinical pilot trial
U D Rohr, C Oberhoff, S Markmann, et al.
Cancer Chemotherapy and Pharmacology
|
September 3, 2013
Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology)
A Mustea, D Koensgen, A Belau, et al.
Brain : a Journal of Neurology
|
September 11, 2012
Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice
K Kollmann, M Damme, S Markmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 9, 2012
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
W Eiermann, M Rezai, S Kümmel, et al.
Scientific Reports
|
July 30, 2024
TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells
D Wünkhaus, R Tang, K Nyame, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Clinical Neurology and Neurosurgery
|
February 19, 2013
Severe acute motor neuropathy after treatment with triple tyrosine kinase inhibitor BIBF 1120 (Nintedanib)
R Patejdl, S Markmann, R Benecke, et al.
Archives of Gynecology and Obstetrics
|
April 4, 2003
Unilateral ovarian agenesis: report of three cases and review of the literature
I Mylonas, S Hansch, S Markmann, et al.
Oncology
|
November 27, 2001
Effectiveness of Trastuzumab (Herceptin) in a patient with locally recurrent breast cancer after cardiac failure caused by severe cytotoxic pretreatment
B Gerber, A Krause, S Markmann, et al.
Annals of Biomedical Engineering
|
June 2, 2018
Toward a Flexible Variable Stiffness Endoport for Single-Site Partial Nephrectomy
E Amanov, T-D Nguyen, S Markmann, et al.
MMW Fortschritte Der Medizin
|
April 28, 2009
[Chronic rhinosinusitis and aspirin intolerance]
A Leunig, F Braunschweig, M Havel, et al.
Archives of Gynecology and Obstetrics
|
November 30, 2005
WITHDRAWN: The safety of synthetic paclitaxel by intralesional delivery with OncoGeltrade mark into skin breast cancer metastases: method and results of a clinical pilot trial
U D Rohr, C Oberhoff, S Markmann, et al.
Cancer Chemotherapy and Pharmacology
|
September 3, 2013
Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology)
A Mustea, D Koensgen, A Belau, et al.
Brain : a Journal of Neurology
|
September 11, 2012
Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice
K Kollmann, M Damme, S Markmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 9, 2012
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
W Eiermann, M Rezai, S Kümmel, et al.
Scientific Reports
|
July 30, 2024
TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells
D Wünkhaus, R Tang, K Nyame, et al.
Page
of 1